Abstract:Ethnopharmacological relevance: Tacrolimus (TAC) was widely used in various renal diseases while high recurrence rate and high expense restricted its applications. Traditional herbal medicine has become increasingly popular as an adjuvant therapy to minimize the adverse effects of TAC. Colquhounia root tablet (CRT), a prescribed drug prepared from the water extract of the peeled root of Tripterygium hypoglaucum (H. Lev.) Hutch., showed excellent anti-inflammatory, analgesic and immunosuppressive pharmacological properties. TAC used in combination with CRT was substantially more efficacious and safer than the monotherapy for the treatment of nephrotic syndrome. However, studies on their herb-drug interaction were scanty. Aim of the study: The study was proposed to examine the effect of CRT on the pharmacokinetics of TAC in rats and identify the key natural constituents in CRT that affected the metabolism of TAC. Materials and methods: TAC was orally and intravenously administered to rats alone or in combination with CRT and the pharmacokinetic parameters of TAC were compared. After pretreatment with CRT for 15 d, the expressions of the drug-metabolizing enzymes (DMEs), drug transporters (DTs) and nuclear receptors (NRs) were determined by polymerase chain reaction and western blotting and compared with the control group. The hepatic microsomal incubation system was employed to confirm the inhibitory effects of CRT and its major components on rat cytochrome P450 (CYP) 3A2. The roles of the primary components in the regulation of human CYP3A4 and mouse P-gp activities were evaluated by using docking analysis. Results: The blood concentrations of TAC were significantly increased in a dose- and pretreatment timedependent manner after combined administration of CRT. The maximal effect was found at 300 mg/kg (43.70 +/- 8.77 ng/mL and 141.45 +/- 21.58 h.ng/mL) in a single dose run and the pharmacokinetic parameters gradually returned to the normal levels at 24 h interval of long-term CRT pretreatment. In contrast, CRT had no effect on the pharmacokinetics of intravenous TAC. Further study indicated that the mRNA and protein expressions of DMEs and DTs, such as CYP3A1, CYP3A2, P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 in rat intestine and liver were down-regulated, whereas the expressions of NRs like constitutive androstane receptor and pregnane X receptor were up-regulated after multiple oral doses of CRT. Molecular docking showed the binding potency of five CRT major constituents with both human CYP3A4 and mouse P-gp. Celastrol, wilforgine and wilforine were the strongest inhibitors towards midazolam metabolism in rat liver microsomes, with the 50% inhibition concentrations being at 8.33 mu M, 22.18 mu M and 22.22 mu M, respectively. Conclusions: Our results revealed that co-dosing of CRT could lead to a significant increase in blood concentration of TAC and this effect could be ascribed to the resultant co-regulation of DMEs, DTs and NRs. Our study provided an experimental basis for the combination use of CRT and TAC in clinical practice.

Quercitrin: a New Immunosuppressant Inhibits Calcineurin*

Quercetin Targets the Interaction of Calcineurin with LxVP-type Motifs in Immunosuppression.

Inhibition of Calcineurin by Quercetin in Vitro and in Jurkat Cells.

Kaempferol: A New Immunosuppressant of Calcineurin

Quercetin Binds To Calcineurin At A Similar Region To Cyclosporin A And Tacrolimus

Quercitrin ameliorates the development of systemic lupus erythematosus-like disease in a chronic graft-versus-host murine model.

Isogarcinol Is A New Immunosuppressant

Novel Immunosuppression Stemming From The Selective Activity Of Chinese Herbal Drugs

The effect of calcineurin activator, extracted from Chinese herbal medicine, on memory and immunity in mice.

Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect in ulcerative colitis

Effect of Different Immunosuppressive Drugs on Calcineurin and Its Mutants

The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth

A Novel Peptide Exerts Potent Immunosuppression by Blocking the Two-Site Interaction of NFAT with Calcineurin

Inhibitory Effects of Traditional Chinese Medicine Colquhounia Root Tablet on the Pharmacokinetics of Tacrolimus in Rats.

One Novel Quinoxaline Derivative As a Potent Human Cyclophilin A Inhibitor Shows Highly Inhibitory Activity Against Mouse Spleen Cell Proliferation

The Therapeutic Mechanism of Chebulae Fructus in the Treatment of Immunosuppression in Chinese Yellow Quail on the Basis of Network Pharmacology

Inhibitory Effects of Quercetin on the Progression of Liver Fibrosis Through the Regulation of NF-кB/IкBα, P38 MAPK, and Bcl-2/Bax Signaling

The Protection of Crocin Against Ulcerative Colitis and Colorectal Cancer via Suppression of NF-κB-Mediated Inflammation

Studies of compound Chinese medicine on immunosuppression mice promoting immune function

Retraction: A Novel Immunosuppressant, Luteolin, Modulates Alloimmunity and Suppresses Murine Allograft Rejection

Curcumin Attenuates Quinocetone Induced Apoptosis and Inflammation Via the Opposite Modulation of Nrf2/HO-1 and NF-kB Pathway in Human Hepatocyte L02 Cells.